Recently, TNFR2 has also been found on the surface of a highly immuno-suppressive tumor-infiltrating subset of Tregs [109], and therapies that target and eliminate Tregs are currently investigated as cancer treatment [377]. The gene discussed is TNFRSF1B; the disease is neoplasm.